Cargando…

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease

Amyloid-β (Aβ) plaques are a neuropathological hallmark of Alzheimer’s disease (AD); however, a significant number of cognitively normal older adults can also have Aβ plaques. Thus, distinguishing AD from cognitively normal individuals with Aβ plaques (NwAβ) based on Aβ plaque detection is challengi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macdonald, Ian R., Maxwell, Selena P., Reid, George A., Cash, Meghan K., DeBay, Drew R., Darvesh, Sultan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438481/ https://www.ncbi.nlm.nih.gov/pubmed/28453492 http://dx.doi.org/10.3233/JAD-170164

Ejemplares similares

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
por: DeBay, Drew R., et al.
Publicado: (2017)

Probing the Peripheral Site of Human Butyrylcholinesterase
por: Macdonald, Ian R., et al.
Publicado: (2012)

No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer’s disease
por: DeBay, Drew R., et al.
Publicado: (2022)

Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study
por: Rosenberry, Terrone L., et al.
Publicado: (2017)

2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
por: Forrestall, Katrina L., et al.
Publicado: (2021)

Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
por: I.R, Macdonald, et al.
Publicado: (2014)

The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology(♦)
por: Podoly, Erez, et al.
Publicado: (2009)

A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer’s disease
por: Darvesh, Sultan, et al.
Publicado: (2023)

Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011)

Molecular forms of butyrylcholinesterase and obesity
por: Boberg, Dellyana R., et al.
Publicado: (2010)

Butyrylcholinesterase K Variant and Alzheimer’s Disease Risk: A Meta-Analysis
por: Wang, Zongcheng, et al.
Publicado: (2015)

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
por: Kumar, Amit, et al.
Publicado: (2018)

Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022)

Highly sensitive quantification of Alzheimer's disease biomarkers by aptamer-assisted amplification
por: Chan, Hei-Nga, et al.
Publicado: (2019)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
por: Jasiecki, Jacek, et al.
Publicado: (2019)

Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
por: Uzairu, Sani Muhammad, et al.
Publicado: (2022)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia
por: Dong, Mei-Xue, et al.
Publicado: (2017)

Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma
por: Jeong, Woo-Hyeon, et al.
Publicado: (2021)

Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Durner, Jürgen
Publicado: (2022)

NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scanner
por: Strugari, Matthew E., et al.
Publicado: (2023)

Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
por: Miao, Shuang, et al.
Publicado: (2022)

Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
por: Makhaeva, Galina F., et al.
Publicado: (2015)

Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022)

O033 Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Harrington, C, et al.
Publicado: (2022)

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease
por: Jones, Mike, et al.
Publicado: (2016)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
por: Matošević, Ana, et al.
Publicado: (2022)

Effects of physical exercise on butyrylcholinesterase in obese adolescents
por: Silva, Isabela M.W., et al.
Publicado: (2012)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Using lymph node swelling as a potential biomarker for successful vaccination
por: Brewer, Kimberly D., et al.
Publicado: (2016)

Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease
por: Arslan, Max, et al.
Publicado: (2022)

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
por: Dantas, Vitor G.L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ba0671gggs2bc8uu2hp2dctbdv